{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:02:23Z","timestamp":1770897743029,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jpba.2018.11.012","type":"journal-article","created":{"date-parts":[[2018,11,11]],"date-time":"2018-11-11T17:01:54Z","timestamp":1541955714000},"page":"509-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS\/MS method: An application to pharmacokinetic study in Sprague Dawley rats"],"prefix":"10.1016","volume":"164","author":[{"given":"Shruti","family":"Surendran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6451-2123","authenticated-orcid":false,"given":"David","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Pokharkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Choulwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Satheeshkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2016","key":"10.1016\/j.jpba.2018.11.012_bib0005","article-title":"The 2016 revision of the World Health Organization (WHO) classification of lymphoid neoplasms","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2018.11.012_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton\u2019s tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpba.2018.11.012_bib0015","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/eji.1830231210","article-title":"The Bruton\u2019s tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages","volume":"23","author":"De Weers","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jpba.2018.11.012_bib0020","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.91.23.11256","article-title":"Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase","volume":"91","author":"Tsukada","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jpba.2018.11.012_bib0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4049\/jimmunol.181.1.288","article-title":"Dual functions of Bruton\u2019s tyrosine kinase and Tec kinase during Fc\u03b3 receptor-induced signaling and phagocytosis","volume":"181","author":"Jongstra-Bilen","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpba.2018.11.012_bib0030","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1742-4658.2011.08073.x","article-title":"Tec family kinases: regulation of Fc\u03b5RI mediated mast cell activation","volume":"278","author":"Ellmeier","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.jpba.2018.11.012_bib0035","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton\u2019s tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2018.11.012_bib0040","unstructured":"Mantle cell lymphoma facts-Leukemia & lymphoma society https:\/\/www.lls.org\/sites\/default\/files\/file_assets\/mantlecelllymphoma.pdf (Accessed on July 2018)."},{"key":"10.1016\/j.jpba.2018.11.012_bib0045","series-title":"Global Cancer: Facts and Figures, American Cancer society","year":"2012"},{"key":"10.1016\/j.jpba.2018.11.012_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1509981","article-title":"Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia","volume":"374","author":"Byrd","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jpba.2018.11.012_bib0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159607","article-title":"Preclinical evaluation of the novel BTK inhibitor acalabrutinib in canine models of B-cell non-Hodgkin lymphoma","volume":"11","author":"Harrington","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.11.012_bib0060","unstructured":"Acalabrutinib https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Acalabrutinib (Accessed on July 2018)."},{"key":"10.1016\/j.jpba.2018.11.012_bib0065","author":"Food and Drug Administration"},{"key":"10.1016\/j.jpba.2018.11.012_bib0070","series-title":"Center for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Methods Validation","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jpba.2018.11.012_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jchromb.2017.01.009","article-title":"A validated LC\u2013MS\/MS method for the estimation of glimepiride and pitavastatin in rat plasma: Application to drug interaction studies","volume":"1046","author":"Surendran","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2018.11.012_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2017.05.026","article-title":"A validated UHPLC-QTOF-MS method for quantification of Metformin and Teneligliptin in rat plasma: application to pharmacokinetic interaction study","volume":"143","author":"Paul","year":"2017","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851831985X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851831985X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T15:34:12Z","timestamp":1548257652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851831985X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":16,"alternative-id":["S073170851831985X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.11.012","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Bruton tyrosine kinase inhibitor acalabrutinib quantification by validated LC-MS\/MS method: An application to pharmacokinetic study in Sprague Dawley rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}